clinical trial · NCT07150663
Nanocrystalline Megestrol Acetate in Concurrent Chemoradiotherapy for Locally Advanced Non-Small Cell Lung Cancer
Changchun GeneScience Pharmaceutical Co., Ltd.·phase3·recruiting·n = 134
Non-small Cell Lung CancerNano-crystalline Megestrol Acetate Oral SuspensionStandard Therapy
brief summary
This study is a prospective, randomized, parallel-controlled clinical trial, primarily aimed at evaluating the efficacy and safety of Nanocrystalline Megestrol Acetate combined with standard therapy, compared with placebo combined with standard therapy, in improving appetite and body weight during concurrent chemoradiotherapy for patients with locally advanced non-small cell lung cancer.
started
Aug 20, 2025
primary completion
Jun 30, 2027
completion
Dec 31, 2027
last updated
Sep 8, 2025
official title
A Prospective, Randomized, Parallel-Controlled Clinical Study of Nanocrystalline Megestrol Acetate in Concurrent Chemoradiotherapy for Locally Advanced Non-Small Cell Lung Cancer
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol